End-stage renal disease (ESRD) is a major public: health problem, affecting
1 in 1,000 individuals and with an annual death rate of 20% despite dialys
is treatment(1,2). IgA nephropathy (IgAN) is the most common form of glomer
ulonephritis, a principal cause of ESRD worldwide(1,2); it affects up to 1.
3% of the population(3-6) and its pathogenesis Is unknown. Kidneys of peopl
e with IgAN show deposits of IgA-containing immune complexes with prolifera
tion of the glomerular mesangium (Fig. 1). Typical clinical features includ
e onset before age 40 with haematuria and proteinuria (blood and protein in
the urine), and episodes of gross haematuria following mucosal infections
are common; 30% of patients develop progressive renal failure(6-9). Althoug
h not generally considered a hereditary disease, striking ethnic variation
in prevalence(1-6,10) and familial clustering(11-16), along with subclinica
l renal abnormalities among relatives of IgAN cases(9,14-16), have suggeste
d a heretofore undefined genetic component. By genome-wide analysis of link
age in 30 multiplex IgAN kindreds, we demonstrate linkage of IgAN to 6q22-2
3 under a dominant model of transmission with incomplete penetrance, with a
lod score of 5.6 and 60% of kindreds linked. These findings for the first
time indicate the existence of a locus with large effect on development of
IgAN and identify the chromosomal location of this disease gene.